Synthetic biology brings meals and medicine closer together

November 02, 2010 | Analyst Insight

Last week, synthetic biology companies Evolva Holding (SIX: EVE) and Abunda Nutrition agreed to extend and expand their current research collaboration, where Abunda uses Evolva’s technology platform to produce high-value food ingredients. For...